Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of brivaracetam at doses of 100 and
200mg/day compared to placebo as adjunctive treatment in adult focal epilepsy subjects with
partial onset seizures not fully controlled despite current treatment with 1 or 2 concomitant
antiepileptic drugs.